VOLO · PORTFOLIO

SoFlux

SoFlux
Licence
NPN 80113974
Launched
2027

For the rapid relief of gastroesophageal reflux disease (GERD) symptoms, including heartburn, acid regurgitation, epigastric pain, and cough.

← Back to portfolio In-license with Volo →
— Also in the portfolio

Other brands we have launched and grown.

ProZema probiotic box and sticks

ProZema

ProZema reduces the symptoms of eczema and atopic dermatitis. Features a unique blend of 3 patented probiotic strains

NPN 80105914 2021
Femistina Plus and capsules

Femistina Plus

Femistina Plus provides round-the-clock defense against recurrent UTIs with its innovative triple-action mechanism. Femistina Plus is designed for use in women with a history of recurrent cystitis who are seeking a structured, non-antibiotic prophylactic strategy. It is positioned as a clinically credible adjunct or alternative to continuous low-dose antibiotic prophylaxis, aligned with global antibiotic stewardship […]

NPN 80096665 2024

Renova

Adjunctive support for patients with chronic kidney disease (CKD) stages 1–3, specifically targeting the reduction of uremic toxin accumulation through gut microbiome modulation. Indicated to support kidney function preservation and reduce systemic inflammation associated with early-stage CKD. Mechanism of Action: A proprietary blend of targeted prebiotics and postbiotics that selectively inhibit the intestinal bacteria responsible […]

In process 2027